tranylcypromine has been researched along with Sarcoma, Ewing in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennani-Baiti, IM; Kovar, H; Llombart-Bosch, A; Machado, I | 1 |
1 other study(ies) available for tranylcypromine and Sarcoma, Ewing
| Article | Year |
|---|---|
Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma.
Topics: Bone Neoplasms; Cell Proliferation; Chondrosarcoma; Gene Expression Profiling; Histone Demethylases; Humans; Osteosarcoma; Rhabdomyosarcoma; Sarcoma, Ewing; Tranylcypromine | 2012 |